When: Tuesday, May 12, 2:00 p.m.–3:00 p.m. Eastern
NARSAD Grantee, 2001, 2003, 2010, 2014
2005 Freedman Award Winner
Ginny & John Eulich Professor
University of Texas Southwestern Medical Center at Dallas
Dr. Lisa Monteggia's lab focuses on the role of the molecular and cellular basis of neural plasticity as it pertains to neuropsychiatric disorders. Her research interest has been focused in two areas. First, she is working on clarifying the mechanisms underlying antidepressant efficacy. Second, she is studying the role of Methyl-CpG-binding protein 2 (MeCP2), the gene linked to the autism spectrum disorder and Rett syndrome, on synaptic plasticity and behavior. Her research encompasses molecular, cellular, behavioral and electrophysiological approaches using mouse models.
Dr. Monteggia is an Associate Editor of Neuropsychopharmacology and a member of the editorial boards of the Journal of Neuroscience, Journal of Biological Chemistry and Biological Psychiatry. She has served on grant review panels for the National Institutes of Health, the National Science Foundation, as well as numerous scientific foundations. She recently was Editor to The Autisms: Molecules to Model Systems published by Oxford University Press.
President & CEO
Brain & Behavior Research Foundation
Dr. Jeffrey Borenstein, a board certified psychiatrist, has dedicated his professional life to the mental health field and to improving the lives of those with mental illness. He also serves as Editor-in-Chief of the American Psychiatric Association’s Psychiatric News, Associate Clinical Professor of Psychiatry at Columbia University College of Physicians and Surgeons and host of the award-winning Public Television series “Healthy Minds,” a program designed to educate people and dispel myths about mental illness.